Eli Lilly has stepped up the pace of development in obesity
Eli Lilly has set its sights on maintaining its grip on the fast-growing market for obesity drugs.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.